within Pharmacolibrary.Drugs.ATC.A;

model A10BA02_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.15,
    adminDuration  = 600,
    adminMass      = 0.85,
    adminCount     = 1,
    Vd             = 0.065,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 780
  );

  annotation(Documentation(
    info ="<html><body><p>Metformin is an oral antihyperglycemic of the biguanide class, used in the treatment of type 2 diabetes mellitus; it is still widely used and approved as first-line therapy.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in patients with renal impairment compared to healthy subjects.</p><h4>References</h4><ol><li><p>Graham, GG, et al., &amp; Williams, KM (2011). Clinical pharmacokinetics of metformin. <i>Clinical pharmacokinetics</i> 50(2) 81–98. DOI:<a href=&quot;https://doi.org/10.2165/11534750-000000000-00000&quot;>10.2165/11534750-000000000-00000</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21241070/&quot;>https://pubmed.ncbi.nlm.nih.gov/21241070</a></p></li><li><p>Scheen, AJ (1996). Clinical pharmacokinetics of metformin. <i>Clinical pharmacokinetics</i> 30(5) 359–371. DOI:<a href=&quot;https://doi.org/10.2165/00003088-199630050-00003&quot;>10.2165/00003088-199630050-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8743335/&quot;>https://pubmed.ncbi.nlm.nih.gov/8743335</a></p></li><li><p>Froldi, G (2024). View on Metformin: Antidiabetic and Pleiotropic Effects, Pharmacokinetics, Side Effects, and Sex-Related Differences. <i>Pharmaceuticals (Basel, Switzerland)</i> 17(4) –. DOI:<a href=&quot;https://doi.org/10.3390/ph17040478&quot;>10.3390/ph17040478</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38675438/&quot;>https://pubmed.ncbi.nlm.nih.gov/38675438</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A10BA02_1;
